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Multiple sclerosis (MS) lesions in the brain are pathologically heterogeneous and demonstrate different imaging patterns on MRI, with variable sizes and appearance; some undergo acute inflammatory changes, while others may show extensive tissue destruction. Larsson et al. first applied diffusion-weighted MR imaging in 1992 in a study of multiple sclerosis (MS). This study and subsequent studies have demonstrated increased molecular diffusion (MD) in lesions of MS patients when compared with the normal white matter of healthy individuals (Larsson HB et Al) . In MS lesions, the highest diffusion values appear to be found in non-enhancing T1-hypointense lesions, compared with enhancing lesions and non-enhancing T1-isointense lesions. Studies of DTI in normal-appearing brain matter (NAWM) have revealed decreased FA and increased MD in different regions that appear normal on conventional MRI. Furthermore, there has been interest in using fiber tractography obtained from DTI datasets to characterize white matter tract directionality and integrity in relation to MS lesions. Haacke et al. has shown how the amount of iron deposition in the brain may serve as a surrogate biomarker for different multiple sclerosis (MS) lesion characteristics (Haacke EM et Al). In their study, SWI was able to show lesions missed by conventional methods, and six different lesion characteristics.
In a recently published study, prominent perivenular spaces were detected on high-resolution transverse T2weighted MR images in patients with multiple sclerosis (Ge Y et Al). The widening of the perivenular space was depicted as a string-like hyperintensity projecting radially and aligned with multiple sclerosis lesions, following the course and configuration of deep venular structures. The appearance of focal MS lesions on SWI, and the differentiation of clinical MS subgroups based on SWI findings, are important questions to be answered in future studies.
There is evidence for a large spectrum of idiopathic inflammatory demyelinating lesions (IIDL) of the central nervous system (CNS), which can cause a wide range of morphologic abnormalities, as shown by magnetic resonance imaging (MRI) of the brain. The majority of reportedly atypical idiopathic inflammatory demyelinating lesions exhibited morphologic characteristics on MRI that could be classified into one of four different subtypes: a) "megacystic"; b) "Balo-like"; c) "infiltrative"; and d) "ring-like" (Seewann A et Al). It is difficult to distinguish atypical MS lesions from neoplastic lesions, based on imaging findings on conventional MR sequences. Recent studies have shown that peripheral restriction on DWI, venular enhancement, and the presence of glutamate (Glx) on MR spectroscopy may be helpful in differentiating atypical MS lesions from neoplastic lesions (Malhotra HS et Al). In one case report, diffusion-weighted imaging findings were described in a 45-year-old female patient with Balo concentric sclerosis (Kavanagh EC et Al). Diffusion-weighted imaging might offer additional insight into the pathophysiology of this rare demyelinating form. In an ongoing multi-center study, the analysis of DWI characteristics in atypical MS forms has shown restricted diffusion in the outer, enhancing layers of Balo-like lesions, probably corresponding to areas of increased inflammatory and demyelinating activity (work in progress). Elevated diffusivity was found in diffuse infiltrating variants that reflect the destructive nature of the disease.
HIV-associated dementia (HAD) is the most advanced stage of central nervous system disease and is caused by human immunodeficiency virus (HIV) in-fection. Typical MR imaging findings on conventional MR sequences in HIV encephalitis/encephalopathy are symmetrical and bilateral hyperintensities in the white matter, without mass effect and enhancement. Subcortical U-fibers are usually not involved. Approximately 80% of HIV-positive patients will have white matter lesions. Four patterns of white matter abnormalities have been described: diffuse; patchy; focal; and punctuate. 1 H MR spectroscopy (MRS) has been used initially for the detection of early CNS involvement by HIV. Decreased NAA and elevated Cho and MI levels (lower NAA/Cr ratio, increased Cho/Cr ratio, increased MI/Cr ratio) in the MR spectrum of the basal ganglia or frontal white matter have been described in early HIV infection of the brain. On perfusion MRI, a statistically significant decrease in rCBF bilaterally in the inferior lateral frontal cortices, and an increase in the posterior inferior parietal white matter will be observed in patients with HAD. Diffusion tensor MR imaging (DTI) has been used in several studies to explore the neurological dysfunction that results from HIV infection (Filippi CG Frontotemporal dementia (FTD) and Alzheimer's disease are difficult to differentiate clinically because of overlapping symptoms. Diffusion tensor imaging (DTI) measurements were shown to be useful in distinguishing the different patterns of white matter degradation between the two dementias (Zhang Y et Al).
The relationships between cognitive impairment, dementia, and subcortical vascular lesions are poorly understood. White matter hyperintensity (WMH) in cerebrovascular disease has been found to be more strongly related to amnestic, mild cognitive impairment (MCI). However, infarcts were more strongly related to nonamnestic MCI (Luchsinger JA et Al).
Progressive multifocal leukoencephalopathy (PML)
is a subacute opportunistic infection caused by the JC Polyomavirus (JCV). The histopathological hallmark of PML is demyelination, with enlarged oligodendroglial nuclei and bizzare astrocytes. PML lesions are patchy, scalloped, high signal-intensity white matter lesions with extension along the white fibers. Mass effect is mild or absent, and peripheral, faint enhancement is rarely observed. On T1-WI images, the PML lesions are markedly hypointense. Recent studies have shown clinical and radiological improvement in patients with PML who underwent highly active antiretroviral therapy (HAART) (Thurnher MM et Al) . Initial worsening of the MR imaging findings, with development of contrast enhancement, mass effect, and edema, was observed in patients who were long-term survivors, as a result of a post-treatment inflammatory reaction due to the immune reconstitutive effect (IRIS).
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated disorder of the CNS. It usually affects children, and the symptoms occur within three weeks of a viral infection, vaccination, or drugs (Tanembaum S et al.; Rossi A et Al) Although ADEM is, by definition, a monophasic disease, studies show that as many as one-third of patients experience relapses in the future. The real significance of the relapsing-remitting variants of ADEM is still questionable, in that they may represent intermediate forms between ADEM and MS. Transitional forms between ADEM and MS exist, and there is still no answer as to why, in some patients, the disease ceases after a monophasic attack, and, in others, progresses to classical MS. At present, there are no clear prognostic factors that determine whether a child with a first event of either ADEM or CIS will eventually develop MS. The risk of developing MS after ADEM has been reported as up to 28%.
The historical definition of Neuromyelitis optica (NMO) is a monophasic disorder consisting of fulminant bilateral ON and myelitis occurring in close temporal association. Epidemiological studies performed during the second half of the 20 th century show clearly that the typical form of demyelinating disease in Africa, Asia, the Far East, and Aboriginal populations is neuromyelitis optica or optic-spinal multiple sclerosis. The relapsing-remitting phenotype, affecting many sites within the brain and spinal cord, is a common form of MS in the European population. According to the clinical studies, extensive demyelination is present in the white and gray matter of the spinal cord, the disease has a relapsing course in 80-90% of patients, and females are more frequently affected (Wingerchuk DM et Al) . The discovery of a highly specific NMO-antibody with high sensitivity and specificity for NMO has significantly improved the early diagnosis of this severe demyelinating syndrome. NMO-IgG reacts with the water channel AQUAPORIN 4 (Watters P et Al). The presence of autoantibodies has been included in new revised criteria, with a specificity of 100%. Ten percent of patients with DNO have brain abnormalities; the periventricular regions, brainstem, and corpus callosum can be affected. Those particular and unique locations correspond with the brain regions with the highest aquaporin 4 concentrations. A study from Japan has brought some new insights: a) patients positive for AQP4 do not show the typical optic-spinal phenotype; b) AQP4 seronegative patients can show the typical phenotype; and c) conversion from NMO to RRMS exists.
Vascular involvement of CNS can occur in any primary systemic vasculitis. Imaging findings are nonspecific and include: diffuse or focal supratentorial areas of increased signal on FLAIR and T2-WI images; multiple subcortical infarcts; large vessel disease with cortical infarcts; patchy enhancement; atrophy; and restricted diffusion on DWI in lesions suggestive of acute stroke. Recent studies using DTI measurements have shown increased whole-brain diffusivity in patients with the diagnosis of NPSLE, increased diffusion (ADC) and a decrease in diffusion anisotropy (FA) in NPSLE and in SLE patients compared to healthy controls, and decreased FA in NPSLE compared to SLE (Zhang et Al; Welsh et Al).
In MS specific diagnostic criteria, and special and temporal dissemination of MRI lesions, are widely used to establish diagnosis and to differentiate MS from variety of other white matter diseases. However, an ex-tensive diagnostic work-up is still needed to exclude and differentiate autoimmune diseases with possible CNS involvement, vasculitis, infections, paraneoplastic syndromes, and a great variety of leukodystrophies.
Advanced quantitative MR techniques have definitely reshaped the picture of MS, and changed our understanding of underlying pathology of MS and other white matter diseases. We are getting closer to the linking of structural, metabolic and functional changes in white matter disorders to quantify the extent and severity of damage in the brain.
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